Skandinaviska Enskilda Banken (SEB)’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-309,359
| Closed | -$3.12M | – | 906 |
|
|
2022
Q4 | $3.12M | Sell |
309,359
-1,972
| -0.6% | -$19.9K | 0.02% | 447 |
|
|
2022
Q3 | $6.98M | Buy |
311,331
+117,694
| +61% | +$2.64M | 0.05% | 297 |
|
|
2022
Q2 | $4.8M | Buy |
193,637
+13,017
| +7% | +$323K | 0.04% | 371 |
|
|
2022
Q1 | $7M | Buy |
180,620
+6,916
| +4% | +$268K | 0.04% | 333 |
|
|
2021
Q4 | $10.4M | Buy |
173,704
+31,753
| +22% | +$1.91M | 0.05% | 281 |
|
|
2021
Q3 | $8.41M | Hold |
141,951
| – | – | 0.05% | 319 |
|
|
2021
Q2 | $12.3M | Buy |
141,951
+119,351
| +528% | +$10.4M | 0.08% | 250 |
|
|
2021
Q1 | $1.86M | Hold |
22,600
| – | – | 0.01% | 686 |
|
|
2020
Q4 | $2.06M | Buy |
22,600
+15,000
| +197% | +$1.36M | 0.01% | 642 |
|
|
2020
Q3 | $304K | Sell |
7,600
-16,300
| -68% | -$652K | ﹤0.01% | 875 |
|
|
2020
Q2 | $820K | Buy |
+23,900
| New | +$820K | 0.01% | 754 |
|